Fetal Monitoring, Diagnostics and Predictive Tests

Single User License: $2750 Member Price: FREE Buy Now

• Membership Options

Report Highlights

The global market for fetal monitoring, diagnostics, and predictive tests reached approximately $6.2 billion in 2010.  The market is expected to rise at a compound annual growth rate (CAGR) of 4.4% and reach approximately $8 billion by 2016.

SCOPE OF THE STUDY

The scope of this study encompasses the fetal monitoring and diagnostics markets.  BCC analyzes each market and its applications by its need for usage in different stages of pregnancy, along with the regulatory environment, technology involved, market projections, and market share.  Technological issues include the latest trends and developments. 

ABOUT THE AUTHOR

The study has been carried out by a team of professionals in the biotechnology industry.  The project manager is Shalini S. Dewan, who holds a Master’s degree in Pharmaceutical Chemistry and has more than 14 years of industry experience.  Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid.  Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and the U.S.  Her other reports with BCC Research include Reagents of Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems: New Developments, New Technologies; Orthopedic Drugs, Implants and Devices; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; Cancer Therapies: Technologies and Global Markets; and Medical Imaging Reagents and Analysis Equipment. 

The lead consultant for this project was Dr. Kapil A. Setia, who holds a doctoral degree in Life Sciences.  She has a number of research publications to her credit, including her thesis on Studies on Phenotypic Variation, Clonal Propagation, and Phyto-chemistry of Tinospora cordifolia (Willd.).